Back to
MACQUARIE GROUP LTD
MRTX22 quarters
Position history for
MACQUARIE GROUP LTD's holdings in MIRATI THERAPEUTICS INC
As of its Q4 2023 13F, Macquarie Group held 60,000 shares of MRTX (Mirati Therapeutics), worth $3.5M. Macquarie Group's 13F filings listed MRTX from Q4 2018 to Q4 2023, 21 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$9.5M
Total Shares Change
-223,630
Quarter-by-Quarter History
Other major holders of MRTX: Avoro Capital Advisors LLC